On Tuesday, Dyne Therapeutics Inc (NASDAQ: DYN) opened higher 2.97% from the last session, before settling in for the closing price of $14.13. Price fluctuations for DYN have ranged from $14.03 to $47.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 12.26% at the time writing. With a float of $77.75 million, this company’s outstanding shares have now reached $101.75 million.
Let’s look at the performance matrix of the company that is accounted for 141 employees. In terms of profitability, gross margin is 64.28%, operating margin of -8301.64%, and the pretax margin is -7774.92%.
Dyne Therapeutics Inc (DYN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 23.60%, while institutional ownership is 86.89%. The most recent insider transaction that took place on Dec 11 ’24, was worth 65,632. In this transaction Chief Scientific Officer of this company sold 2,334 shares at a rate of $28.12, taking the stock ownership to the 201,685 shares. Before that another transaction happened on Dec 11 ’24, when Company’s SVP, Head of Finance & Admin. sold 1,455 for $28.12, making the entire transaction worth $40,915. This insider now owns 127,078 shares in total.
Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.26% per share during the next fiscal year.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 17.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -3.77 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc (NASDAQ: DYN) saw its 5-day average volume 2.56 million, a positive change from its year-to-date volume of 2.55 million. As of the previous 9 days, the stock’s Stochastic %D was 2.31%. Additionally, its Average True Range was 1.61.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 1.74%, which indicates a significant decrease from 4.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 156.95% in the past 14 days, which was higher than the 100.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.64, while its 200-day Moving Average is $32.07. Nevertheless, the first resistance level for the watch stands at $14.86 in the near term. At $15.16, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.60. If the price goes on to break the first support level at $14.12, it is likely to go to the next support level at $13.68. Assuming the price breaks the second support level, the third support level stands at $13.38.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 101,766K shares outstanding in the company with a market cap of 1.48 billion. Presently, the company’s annual sales total 0 K according to its annual income of -235,940 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -97,130 K.
